<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-FGHKGHUX/fbef2c4f-4906-4339-9da2-39e55426082b/PDF"><dcterms:extent>107 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-FGHKGHUX/b7a5b920-a9a1-42f3-be65-890dc02dfe91/TEXT"><dcterms:extent>27 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1994-2025"><edm:begin xml:lang="en">1994</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:DOC-FGHKGHUX"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-46R7GGHL" /><dcterms:issued>2006</dcterms:issued><dc:creator>Bevc, Sebastjan</dc:creator><dc:creator>Ekart, Robert</dc:creator><dc:creator>Hojs, Radovan</dc:creator><dc:format xml:lang="sl">številka:3</dc:format><dc:format xml:lang="sl">letnik:45</dc:format><dc:format xml:lang="sl">str. 293-299</dc:format><dc:identifier>ISSN:0025-8121</dc:identifier><dc:identifier>COBISSID:2579007</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-FGHKGHUX</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Medicinski razgledi</dc:publisher><dcterms:isPartOf xml:lang="sl">Medicinski razgledi</dcterms:isPartOf><dc:subject xml:lang="sl">Cistatini</dc:subject><dc:subject xml:lang="en">Creatinine</dc:subject><dc:subject xml:lang="en">Cystatins</dc:subject><dc:subject xml:lang="en">diagnosis</dc:subject><dc:subject xml:lang="en">Diagnostika</dc:subject><dc:subject xml:lang="en">Glomerular Filtration Rate</dc:subject><dc:subject xml:lang="sl">Glomerularna filtracija, hitrost</dc:subject><dc:subject xml:lang="sl">glomerulna filtracija</dc:subject><dc:subject xml:lang="en">Kidney Diseases</dc:subject><dc:subject xml:lang="sl">Kreatinin</dc:subject><dc:subject xml:lang="sl">Ledvica, bolezni</dc:subject><dc:subject xml:lang="sl">ledvične bolezni</dc:subject><dc:subject rdf:resource="http://www.wikidata.org/entity/Q9377" /><dcterms:temporal rdf:resource="1994-2025" /><dc:title xml:lang="sl">Serumski cistatin C - nov označevalec glomerulne filtracije| Serum cystatin C - a new marker of glomerular filtration rate|</dc:title><dc:description xml:lang="sl">The glomerular filtration rate (GFR) is the main indicator of kidney function and GFR estimation is essential for the evaluation of patients with chronic kidney disease. In clinical practice, serum creatinine levels and creatinine clearance are the most commonly used markers to estimate GFR. The standard GFR estimation method is based on the clearance of a radionuclide-labelled marker. Recently, serum cystatin C has been proposed as a new endogenous GFR marker. This protease inhibitor with a low molecular weight is produced at a constant rate by all nucleated cells and is freely filtered across the glomerular membrane. Contrary to serum creatinine, serum cystatin C does not depend on muscle mass, sex, age or dietary protein intake. This study confirmed that serum cystatin C is a reliable marker of GFR. Serum cystatin C had a higher diagnostic accuracy than serum creatinine and also creatinine clearance in well-defined patients with chronic kidney disease</dc:description><dc:description xml:lang="sl">Glomerulna filtracija (GF) je najpomembnejši pokazatelj ledvične funkcije. Ocena GF je pomembna za obravnavo in spremljanje bolnika z ledvično boleznijo. V vsakdanji klinični praksi se za oceno GF najpogosteje uporabljata koncentracija serumskega kreatinina in očistek kreatinina, kot standardna referenčna metoda za določanje GF pa očistek radioizotopnega označevalca. V zadnjem času se kot eden novih označevalcev glomerulne filtracije pojavlja serumski cistatin C, inhibitor proteaz, ki v telesu nastaja stalno v vseh jedrnih celicah in se zaradi svoje majhnosti prosto filtrira v glomerulu. Za razliko od kreatinina koncentracija cistatina C ni odvisna od mišične mase, starosti, spola in načina ter vrste prehrane. Številne raziskave so potrdile, da je serumski cistatin C dober označevalec GF. V določenih populacijah bolnikov z ledvično boleznijo se je koncentracija serumskega cistatina C pokazala kot boljši pokazatelj GF od koncentracije serumskega kreatinina</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:DOC-FGHKGHUX"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:DOC-FGHKGHUX" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:DOC-FGHKGHUX/fbef2c4f-4906-4339-9da2-39e55426082b/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Društvo Medicinski razgledi</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:DOC-FGHKGHUX/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:DOC-FGHKGHUX" /></ore:Aggregation></rdf:RDF>